Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
$11.18
+3.9%
$8.68
$4.60
$14.44
$918.60M0.721.19 million shs1.10 million shs
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
$2.11
-0.9%
$18.71
$3.05
$21.08
$23.49M1.92122,925 shs182,151 shs
Cannabis Wheaton Income Corp. stock logo
CBWTF
Cannabis Wheaton Income
$0.10
-5.4%
$0.07
$0.02
$0.13
$146.21M1.041.38 million shs3.10 million shs
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$0.85
+1.2%
$0.65
$0.22
$3.39
$28.87M1.96191,274 shs4,863 shs
Starpharma Holdings Ltd. stock logo
SPHRY
Starpharma
$0.63
-1.9%
$0.58
$0.47
$0.80
$26.22M0.76167 shs500 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
+3.90%+4.29%+37.68%+26.19%+141.99%
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
+0.47%+5.19%-29.24%+51.06%+21.71%
Cannabis Wheaton Income Corp. stock logo
CBWTF
Cannabis Wheaton Income
-5.39%+13.10%+78.31%+78.31%+368.78%
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
+1.19%-10.05%+13.33%+41.67%-70.79%
Starpharma Holdings Ltd. stock logo
SPHRY
Starpharma
0.00%-1.89%+2.97%+6.27%+4.50%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
3.6215 of 5 stars
3.70.00.04.71.30.80.6
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
N/AN/AN/AN/AN/AN/AN/AN/A
Cannabis Wheaton Income Corp. stock logo
CBWTF
Cannabis Wheaton Income
0.9466 of 5 stars
0.05.00.00.00.60.01.3
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
0.1449 of 5 stars
0.01.00.00.01.31.70.0
Starpharma Holdings Ltd. stock logo
SPHRY
Starpharma
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
3.33
Buy$44.00293.56% Upside
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
0.00
N/AN/AN/A
Cannabis Wheaton Income Corp. stock logo
CBWTF
Cannabis Wheaton Income
0.00
N/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
0.00
N/AN/AN/A
Starpharma Holdings Ltd. stock logo
SPHRY
Starpharma
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
N/AN/AN/AN/A$1.42 per shareN/A
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
$60.47M0.39$0.00 per share558.40$0.69 per share3.06
Cannabis Wheaton Income Corp. stock logo
CBWTF
Cannabis Wheaton Income
$89.29M1.55N/AN/A$0.06 per share1.73
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$116.61M0.25$0.28 per share3.03N/A
Starpharma Holdings Ltd. stock logo
SPHRY
Starpharma
$6.40M4.10N/AN/A$0.45 per share1.39
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
-$43M-$0.55N/AN/AN/AN/A-40.93%-36.38%8/5/2025 (Estimated)
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
-$4.68M-$0.35N/A52.75N/A-7.75%-42.74%-6.38%N/A
Cannabis Wheaton Income Corp. stock logo
CBWTF
Cannabis Wheaton Income
-$11.93M$0.0110.37N/A16.56%18.53%8.13%N/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$9.28MN/A0.00N/AN/AN/AN/AN/A
Starpharma Holdings Ltd. stock logo
SPHRY
Starpharma
-$5.36MN/A0.00N/AN/AN/AN/A8/20/2025 (Estimated)

Latest SPHRY, LUNA, AVXL, BASI, and CBWTF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q3 2025
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
-$0.13N/AN/AN/AN/AN/A
5/15/2025Q1 2025
Cannabis Wheaton Income Corp. stock logo
CBWTF
Cannabis Wheaton Income
N/A$0.01N/A$0.01N/AN/A
5/13/2025Q2 2025
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
-$0.16-$0.13+$0.03-$0.13N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
N/AN/AN/AN/AN/A
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
N/AN/AN/AN/AN/A
Cannabis Wheaton Income Corp. stock logo
CBWTF
Cannabis Wheaton Income
N/AN/AN/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
N/AN/AN/AN/AN/A
Starpharma Holdings Ltd. stock logo
SPHRY
Starpharma
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
N/A
6.74
6.74
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
2.49
0.48
0.46
Cannabis Wheaton Income Corp. stock logo
CBWTF
Cannabis Wheaton Income
0.02
0.68
0.34
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
N/AN/AN/A
Starpharma Holdings Ltd. stock logo
SPHRY
Starpharma
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Anavex Life Sciences Corp. stock logo
AVXL
Anavex Life Sciences
4085.37 million75.64 millionOptionable
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
39711.13 millionN/ANot Optionable
Cannabis Wheaton Income Corp. stock logo
CBWTF
Cannabis Wheaton Income
3691.34 billion1.26 billionNot Optionable
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
39033.96 million31.38 millionOptionable
Starpharma Holdings Ltd. stock logo
SPHRY
Starpharma
4541.82 millionN/ANot Optionable

Recent News About These Companies

SPHRY Starpharma Holdings Limited
Starpharma CEO Receives Major Performance Rights Issuance
Starpharma Issues Unquoted Securities to Boost Employee Incentives
Starpharma Holdings Reports Successful AGM Results
Starpharma AGM Results Highlight Voting Challenges
Starpharma Highlights Dendrimer Technology at Healthcare Conference
Starpharma Showcases Dendrimer Innovations at Microcap Conference
Medicxi and Starpharma to develop dendrimer-based cancer treatments
Starpharma Holdings Ltd. ADR
News - Starpharma

New MarketBeat Followers Over Time

Media Sentiment Over Time

Anavex Life Sciences stock logo

Anavex Life Sciences NASDAQ:AVXL

$11.18 +0.42 (+3.90%)
Closing price 07/10/2025 04:00 PM Eastern
Extended Trading
$11.14 -0.04 (-0.36%)
As of 08:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.

Bioanalytical Systems stock logo

Bioanalytical Systems NASDAQ:BASI

Bioanalytical Systems, Inc., doing business as Inotiv, provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. BioVaxys has an agreement with Inotiv to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

Cannabis Wheaton Income stock logo

Cannabis Wheaton Income OTCMKTS:CBWTF

$0.10 -0.01 (-5.39%)
As of 07/10/2025 03:56 PM Eastern

Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. It focuses on developing, manufacturing, and distributing cannabis products for wellness and recreational consumers. The company offers cannabis products under various forms, including vape catridges, infused pre-rolls, pre-rolled, vape pens, milled and dried flower, concentrates, chocolates, soft chews, oil drops, capsules, and topicals under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. The company was incorporated in 1987 and is headquartered in Toronto, Canada.

Luna Innovations stock logo

Luna Innovations NASDAQ:LUNA

$0.85 +0.01 (+1.19%)
As of 07/10/2025 03:11 PM Eastern

Luna Innovations Incorporated provides fiber optic test, measurement, and control products worldwide. The company offers test and measurement equipment for fiber optic components and sub-assemblies; polarization control products, including components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; and single frequency lasers. It also provides ODiSI sensing solution, which provides distributed strain and temperature measurements; distributed temperature sensing system; hyperion sensing products; Terahertz Sensing Systems that provide precise single and multi-layer thickness, density, basis weight, and caliper thickness measurements; and distributed acoustic sensing products. The company primarily markets its fiber optic test, measurement, and control products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was incorporated in 1990 and is headquartered in Roanoke, Virginia.

Starpharma stock logo

Starpharma OTCMKTS:SPHRY

$0.63 -0.01 (-1.89%)
As of 07/9/2025 10:39 AM Eastern

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom. It is also involved in the development of DEP cabazitaxel that is in Phase 2 clinical trial for the treatment of prostate and other cancers, DEP docetaxel that is in Phase 2 clinical trials for the treatment of colorectal and other cancers, DEP irinotecan that is in Phase 2 clinical trials f for the treatment of pancreatic and other cancers; and EP gemcitabine, DEP HER-2 ADC, and DEP HER-2 radiotherapy completed preclinical trials for the treatment of solid cancers. In addition, the company's DEP radiotheranostics development pipeline includes DEP HER2-zirconium, a HER2-targeted radio diagnostic for HER2-positive cancers, such as breast and gastric cancer; and HER2-targeted DEP SN38 ADC, a targeted ADC therapeutic for the treatment of human ovarian cancer. Starpharma Holdings Limited was incorporated in 1997 and is headquartered in Abbotsford, Australia.